Direct To Patient
Eurofins CDMO network of companies set up worldwide Direct-To-Patients solutions to enable sponsors to speed up the enrollment in their clinical trials, increase patients engagement and adherence particularly during lengthy and complex studies by facilitating their life with home delivery and home care services.
The strong benefits of the Direct-To-Patients approach in Clinical Trials are fully established with a strong acceleration linked to COVID crisis:
For Patients:
For Patients:
- Reduced travels
- Reduced number of clinic visits
- Improved Quality of Life
For Sponsors:
- Increased enrollment rates
- Lower dropout rates of patients
- Decreased cost per patient
- Guaranteed chain of custody and temperature
For further details, please contact us!
